Document:

AMENDMENT
NO. 3 TO

    EMPLOYMENT
AGREEMENT

     

    This
AMENDMENT NO. 3 (“Amendment”) to that certain Employment Agreement, dated August
29, 2007 (collectively, “Agreement”), by and between NexCen Brands, Inc. (the
“Company”) and Sue Nam (“Executive” or “you”), is made effective as of June 30,
2009 (the “Effective Date”).

    

    WHEREAS,
the Company and the Executive entered into Amendment No. 1 to the Agreement as
of June 30, 2008; and

    

    WHEREAS,
the Company and the Executive entered into Amendment No. 2 to the Agreement as
of September 26, 2008; and

    

    WHEREAS, the Compensation Committee of
the Company’s Board of Directors has approved this Amendment No. 3 and the
changes to the Agreement that it will effect.

    

    NOW,
THEREFORE, for good and valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, the undersigned agree as follows:

    

    
      	
              Section
      1. 

            	
              Amendments.  The
      Agreement shall be amended as
follows:

            

    

    

    
      	
            	
              A.

            	
              Section
      1.3(b)(i) and (b)(iii) shall be deleted in its entirety and replaced with
      the following:

            

    

    

    
      	
               
      

            	
              (b)

            	
              Retention
      Bonus.

            

    

    

    
      	
               
      

            	
              (i)

            	
              Quarterly
      Bonus.  Subject to the Executive’s continued employment
      with the Company from the Effective Date hereof to the end of each
      calendar quarter, Executive shall be entitled to receive a bonus of
      $29,000 for each calendar quarter during the Employment Period, commencing
      with the calendar quarter ended September 30, 2009 (each such payment, a
      “Quarterly Bonus”).  Each Quarterly Bonus earned by Executive
      shall be paid in the final payroll period ending in the calendar quarter
      to which it relates.  Notwithstanding the foregoing, in the
      event of the Executive’s termination by the Company without Cause or the
      Executive’s resignation with Good Reason, the Executive shall be entitled
      to be paid an amount of Quarterly Bonus that is prorated based on the
      number of days the Executive was employed with the Company during the
      quarter through the date of separation from the
  Company.

            

    

    

    
      	
               
      

            	
              (iii)

            	
              Additional
      Transactional Bonus.  Subject to the Executive’s
      continued employment with the Company from the Effective Date hereof to
      the completion of each of the applicable transactions, Executive shall be
      entitled to receive the following transactional bonuses to be paid in the
      Company’s regular payroll period following the consummation of each such
      transaction:

            

    

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    
      	
               
      

            	
              ·

            	
              Additional
      cash bonus of $50,000 upon the successful closing of a transaction for the
      recapitalization of the Company, refinancing of the Company’s debt or a
      Change of Control (as defined in the
Plan).

            

    

    
      	
               
      

            	
              ·

            	
              Additional
      cash bonus of $50,000 upon the filing with the Securities and Exchange
      Commission all financial reports for fiscal year 2009 deemed necessary by
      the Company.

            

    

    

    
      	
            	
              B.

            	
              Section
      1.4(b) and (c) shall be deleted in its entirety and replaced with the
      following:

            

    

    

    (b)            Severance Upon Termination
Without Cause, Upon Resignation by the Executive For Good Reason or Failure to
Renew Term. If the Employment Period is terminated by the Company without
Cause or if the Executive resigns for Good Reason, or if the Company fails to
renew the Term (in which case termination of the Executive’s employment shall be
effective at the expiration of the then-current Term), then the Executive will
be entitled to receive (1) any unpaid Base Salary through and including the
date of termination or resignation and any other amounts, including any declared
but unpaid Annual Bonus or other entitlements then due and owing to the
Executive as of the Termination Date; (2) the sum of (i) the
Executive’s Base Salary (at the rate in effect on the date of termination) for a
twelve-month period following the Executive’s termination of employment as
described in this Section 1.4(b) and (ii) the amount of bonuses paid
to Executive in the prior twelve-month period, payable in (A) substantially
equal installments over the lesser of (i) a six-month period immediately
following such termination, or (ii) such shorter period that is the longest
period permissible in order for the payments not to be considered “nonqualified deferred
compensation” under Section 409A of the Code or any regulations,
rulings or other regulatory guidance issued thereunder, or, if such payment
terms would not satisfy the requirements of Section 409A of the Code and
the regulations, rulings and other regulatory guidance issued thereunder, or
(B) if such payment terms would not satisfy the requirements of Section
409A of the Code and the regulations, rulings and other regulatory guidance
issued thereunder, a lump sum on the date that is six months following the
Executive’s “separation from
service” (within the meaning of Section 409A of the Code) occurring
in connection with such termination and (3) continue to participate in the
Company’s group medical plan on the same basis as he previously participated
or receive
payment of, or reimbursement for, COBRA premiums (or, if COBRA coverage is not
available, reimbursement of premiums paid for other medical insurance in an
amount not to exceed the COBRA premium) for a twelve-month period following the
Executive’s termination of employment; provided that if the
Executive is provided with health insurance coverage by a successor employer,
any such coverage by the Company shall cease (each of (1), (2) and
(3) referred to as the “Severance Payment”). The
Executive also shall be entitled to receive payment for all reimbursable
expenses or other entitlements then due and owing to the Executive as of the
Termination Date. If the Executive breaches his obligations under
Section 1.6, 1.7, 1.8 or 1.9 of this Agreement, the Company’s obligation to
make any Severance Payments and provide any Benefits shall cease as of the date
of such breach; provided, that if the Executive cures such breach within
10 days of receiving written notice from the Company of such breach (which
notice the Company shall provide promptly to the Executive after learning of
such breach), the Company shall promptly pay all Severance Payments not made
during such period of dispute and resume making Severance Payments and providing
Benefits promptly following such cure.

    

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    (c)           Severance upon a Change of
Control. Anything contained herein to the contrary notwithstanding, in
the event the Executive’s employment hereunder is terminated within twelve (12)
months following a Change of Control (as defined in the Plan) by the Company
without Cause or by the Executive with Good Reason, the Executive shall be
entitled to receive the Severance Payment as described in sub-section
(b) above; provided, however, that if such severance payment, either alone
or together with other payments or benefits, either cash or non-cash, that the
Executive has the right to receive from the Company, including, but not limited
to, accelerated vesting or payment of any deferred compensation, options, stock
appreciation rights or any benefits payable to the Executive under any plan for
the benefit of employees, would constitute an “excess parachute payment”
(as defined in Section 280G of the Internal Revenue Code of 1986), then
such severance payment or other benefit shall be reduced to the largest amount
that will not result in receipt by the Executive of an “excess parachute payment.”
The payment reduction contemplated by the preceding sentence, if applicable,
shall be implemented by determining the “Parachute Payment Ratio” (as
defined below) for each parachute payment and then reducing the parachute
payments in order beginning with the parachute payment with the highest
Parachute Payment Ratio.  For parachute payments with the same
Parachute Payment Ratio, such parachute payments shall be reduced based on the
time of payment of such parachute payments, with amounts having later payment
dates being reduced first.  For parachute payments with the same
Parachute Payment Ratio and the same time of payment, such parachute payments
shall be reduced on a pro rata basis (but not below zero) prior to reducing
parachute payments with a lower Parachute Payment Ratio.  For purposes
hereof, the term “Parachute
Payment Ratio” shall mean a fraction the numerator of which is the value
of the applicable parachute payment for purposes of Section 280G of the Code and
the denominator of which is the intrinsic value of such parachute payment. The
determination of the amount of the payment described in this subsection shall be
made by the Company’s independent auditors at the sole expense of the Company.
For purposes of clarification the value of any options described above will be
determined by the Company’s independent auditors using a Black-Scholes valuation
methodology. If within twelve (12) months after the occurrence of a Change
of Control, the Company shall terminate the Executive’s employment without Cause
or the Executive terminates his employment with Good Reason, then
notwithstanding the vesting and exercisability schedule in any stock option or
other grant agreement between the Company and the Executive, all unvested stock
options, shares of restricted stock and other equity awards granted by the
Company to the Executive pursuant to any such agreement shall immediately vest,
and all such stock options shall become exercisable and shall remain exercisable
for the greater of the period provided for in the grant agreement, 180 days
after the effective date of termination of the Executive’s employment, or the
remaining term of the applicable option.

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

     

    
      	
            	
              C.

            	
              A
      new Section 1.4(i) shall be added as
follows:

            

    

    

    (i)           Specified
Employee.  Notwithstanding any other payment schedule provided
herein to the contrary, if Executive is deemed on the date of termination to be
a “specified employee” within the meaning of that term under Code Section
409A(a)(2)(B), then each of the following shall apply:  (A) with
regard to any payment that is considered deferred compensation under Code
Section 409A payable on account of a “separation from service,” such payment
shall be made on the date which is the earlier of (A) the expiration of the six
(6)-month period measured from the date of such “separation from service” of
Executive, and (B) the date of Executive’s death (the “Delay Period”) to the extent
required under Code Section 409A.  Upon the expiration of the Delay
Period, all payments delayed pursuant to this Section shall be paid to Executive
in a lump sum, and all remaining payments due under this Agreement shall be paid
or provided in accordance with the normal payment dates specified for them
herein; and (B) to the extent that any benefits to be provided during the Delay
Period is considered deferred compensation under Code Section 409A provided on
account of a “separation from service,” and such benefits are not otherwise
exempt from Code Section 409A, Executive shall pay the cost of such benefits
during the Delay Period, and the Company shall reimburse Executive, to the
extent that such costs would otherwise have been paid by the Company or to the
extent that such benefits would otherwise have been provided by the Company at
no cost to Executive, the Company’s share of the cost of such benefits upon
expiration of the Delay Period, and any remaining benefits shall be reimbursed
or provided by the Company in accordance with the procedures specified
herein.

    

    Section
2.       Effect of
Amendment.  Except as set forth in Section 1 of this Amendment, the
provisions of the Agreement shall not be amended or altered by this Amendment
and shall continue in full force and effect.

    

    Section
3.       Miscellaneous.  This
Amendment shall be governed by the internal laws of the State of New
York.  This Amendment may be executed in one or more counterparts,
each of which when executed and delivered shall be deemed to be an original and
all counterparts taken together shall constitute one and the same
instrument.  This Amendment and the Agreement (as amended hereby)
constitute the entire understanding of the parties hereto with respect to the
subject matter hereof, and any and all prior agreements and understandings
between the parties regarding the subject matter hereof, whether written or
oral, except for the Agreement (as amended hereby), are superceded by this
Amendment.  Any provision of this Amendment which is invalid or
unenforceable in any jurisdiction shall be ineffective to the extent of such
invalidity or unenforceability without invalidating or rending unenforceable the
remaining provisions hereof, and any invalidity or unenforceability in any
jurisdiction shall not invalidate or render unenforceable such provision in any
other jurisdiction.

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    IN
WITNESS WHEREOF, this Amendment has been duly executed and delivered by the
undersigned parties on December 15, 2009.

     

    
      
        
          	
                  COMPANY:

                
	 
      
	
                  NEXCEN
      BRANDS, INC.

                
	 
      	 
      
	
                  By:

                	
                  /s/ Kenneth J. Hall

                
	
                  Name:
      Kenneth J. Hall

                
	
                  Title:  
      Chief Executive Officer

                
	 
      
	
                  EXECUTIVE:

                
	 
      
	
                  /s/ Sue Nam

                
	
                  Sue
      Nam

                

        

      

    

     

    
      
         

      

      
        5Unassociated Document

     

    SHAREHOLDER
VOTING AGREEMENT

     

    This
SHAREHOLDER VOTING AGREEMENT (this “Agreement”) is entered into as
of December 14, 2009, by and among Fresenius USA, Inc., a Massachusetts
corporation (“Acquiror”)
and the stockholders of Xcorporeal, Inc., a Delaware corporation (the “Company”), identified on Schedule A attached
hereto (each a “Stockholder” and collectively,
the “Stockholders”).

     

    WITNESSETH:

     

    WHEREAS,
as of the date hereof, each Stockholder “beneficially owns” (as such term is
defined in Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as
amended) and is entitled to dispose of (or to direct the disposition of) and to
vote (or to direct the voting of) that total number of shares of common stock,
par value $0.0001 per share (the “Common Stock”), of the Company
as are set forth adjacent to such Stockholder’s name on Schedule A attached
hereto (the “Owned
Shares”), as such shares may be adjusted after the date hereof by stock
dividend, stock split, recapitalization, combination, acquisition,
consolidation, reorganization or other change in the capital structure of the
Company affecting the Common Stock (such shares of Common Stock, together with
any other shares of Common Stock the voting power over which is acquired by a
Stockholder during the period from and including the date hereof through and
including the date on which this Agreement is terminated in accordance with its
terms, are collectively referred to herein as the “Subject Shares”);

     

    WHEREAS,
Acquiror, the Company, Xcorporeal Operations, a Delaware corporation and a
wholly owned subsidiary of the Company (“Operations”) and National Quality
Care, Inc., a Delaware corporation (“NQCI”) propose to enter into
an Asset Purchase Agreement dated as of the date hereof (the “Purchase Agreement”), pursuant
to which Acquiror will purchase certain assets of the Company, Operations and
NQCI, (the “Acquisition”);
and

     

    WHEREAS,
as a condition to the willingness of Acquiror to enter into the Purchase
Agreement, and as an inducement and in consideration therefor, Acquiror has
required that the Stockholders agree, and the Stockholders have agreed, to enter
into this Agreement.

     

    NOW,
THEREFORE, in consideration of the foregoing and the mutual premises,
representations, warranties, covenants and agreements contained herein, the
parties hereto, intending to be legally bound, hereby agree as
follows:

     

    ARTICLE
I

    DEFINITIONS

     

    Section
1.1.          Capitalized Terms. For
purposes of this Agreement, capitalized terms used and not defined herein shall
have the respective meanings ascribed to them in the Purchase
Agreement.

    
      
         

      

      
        
        

        
          

        

      

      
         

      

    

     

    ARTICLE
II

    VOTING
AGREEMENT AND IRREVOCABLE PROXY

     

    Section
2.1.          Agreement to Vote the Subject
Shares. Each Stockholder, in its capacity as such, hereby agrees that,
during the period commencing on the date hereof and continuing until the
termination of this Agreement (such period, the “Voting Period”), at any
meeting (or any adjournment or postponement thereof) of the holders of any class
or classes of the capital stock of the Company, however called, such Stockholder
shall vote or cause to be voted the Subject Shares (a) in favor of the approval
of the terms of the Purchase Agreement, the Acquisition and the other
transactions contemplated by the Purchase Agreement (and any actions required in
furtherance thereof), (b) against any action, proposal, transaction or agreement
that would result in a breach in any respect of any covenant, representation or
warranty or any other obligation or agreement of the Company under the Purchase
Agreement or of such Stockholder contained in this Agreement, and (c) except as
otherwise agreed to in writing in advance by Acquiror, against any action or
proposal involving the Company that is intended, or could reasonably be
expected, to prevent, impede, interfere with, delay, postpone or adversely
affect the transactions contemplated by the Purchase Agreement.  Any
such vote shall be cast or consent shall be given in accordance with such
procedures relating thereto so as to ensure that it is duly counted for purposes
of determining that a quorum is present and for purposes of recording the
results of such vote or consent. During the Voting Period, each Stockholder
agrees not to enter into any written or oral contract, agreement, commitment,
letter of intent, agreement in principle, or understanding with any Person that
violates or conflicts with or could reasonably be expected to violate or
conflict with the provisions and agreements contained in this
Agreement.

     

    Section
2.2.          Grant of Irrevocable Proxy.
Each Stockholder hereby appoints Acquiror and any designee of Acquiror, and each
of them individually, as such Stockholder’s proxy and attorney-in-fact, with
full power of substitution and resubstitution, to cause such Stockholder’s
shares to be counted as present at any meeting of the Company’s Stockholders
during the Voting Period and to vote or act by written consent during the Voting
Period with respect to the Subject Shares in accordance with Section 2.1.
This proxy is given to secure the performance of the duties of such Stockholder
under this Agreement. Each Stockholder shall promptly cause a copy of this
Agreement to be deposited with the Company at its principal place of business.
Each Stockholder shall take such further action or execute such other
instruments as may be reasonably necessary to effectuate the intent of this
proxy. Each Stockholder hereby revokes all other proxies and powers of attorney
with respect to its Subject Shares that it may have previously granted, in each
case to the extent such prior or subsequent proxies or powers of attorney would
prevent such Stockholder from complying with such Stockholder’s obligations
under this Agreement.

     

    Section
2.3.          Nature of Irrevocable Proxy.
The proxy and power of attorney granted pursuant to Section 2.2 by each
Stockholder shall be irrevocable during the Voting Period, shall be deemed to be
coupled with an interest sufficient in law to support an irrevocable proxy and
shall revoke any and all prior proxies granted by such Stockholder. The power of
attorney granted by each Stockholder herein is a durable power of attorney and
shall survive the dissolution, bankruptcy, death or incapacity of such
Stockholder. The proxy and power of attorney granted hereunder shall immediately
terminate upon the termination of this Agreement pursuant to Section
5.1.

     

    Section
2.4.          Other
Rights.  Except as provided by this Agreement or the Purchase
Agreement, each Stockholder shall exercise the full rights of a holder of
capital stock of the Company with respect to the Subject Shares and all economic
benefits of and relating to the Subject Shares shall remain vested in and belong
to such Stockholder.

     

    Section
2.5.          Stockholder
Capacity.   Each Stockholder is executing this Agreement
solely in its capacity as an owner of the Subject Shares, and nothing in this
Agreement shall limit or affect any actions taken by such Stockholder in such
Stockholder’s fiduciary capacity as an officer or director of the
Company.

     

    ARTICLE
III

    COVENANTS

     

    Section
3.1.          Generally.  Each
Stockholder agrees that during the Voting Period, except as contemplated by the
terms of this Agreement, such Stockholder shall not (i) sell, transfer, tender,
pledge, encumber, assign or otherwise dispose of (collectively, a “Transfer”), or enter into any
contract, option or other agreement with respect to, or consent to, a Transfer
of, any or all of the Subject Shares, (ii) grant any proxy, power of attorney,
or other authorization in or with respect to the Subject Shares, or (iii) take
any action that would have the effect of preventing, impeding, interfering with
or adversely affecting its ability to perform its obligations under this
Agreement.

    
      
         

      

      
        - 2
-

        
          

        

      

      
         

      

    

     

    Section
3.2.          Standstill Obligations of
Stockholders. Each Stockholder covenants and agrees with Acquiror that,
during the Voting Period:

     

    (a)           Such
Stockholder shall not, nor shall such Stockholder permit any of its controlled
Affiliates to, nor shall such Stockholder act in concert with or permit any of
its controlled Affiliates to act in concert with any Person to make, or in any
manner participate in, directly or indirectly, a “solicitation” of “proxies” (as
defined in the rules and regulations of the Securities and Exchange Commission)
or powers of attorney or similar rights to vote, or seek to advise or influence
any Person with respect to the voting of, any shares of Common Stock in
connection with any vote or other action on any matter, other than to recommend
that Stockholders of the Company vote in favor of the Acquisition and the
Purchase Agreement and otherwise as expressly provided by Article II of this
Agreement.

     

    (b)           Such
Stockholder shall not, nor shall such Stockholder permit any of its controlled
Affiliates to, nor shall such Stockholder act in concert with or permit any of
its controlled Affiliates to act in concert with any Person to, deposit any
shares of Common Stock in a voting trust or subject any shares of Common Stock
to any arrangement or agreement with any Person with respect to the voting of
such shares of Common Stock except as provided by Article II of this
Agreement.

     

    (c)           Such
Stockholder shall not, and shall cause its Representatives not to, directly or
indirectly: (i) submit, solicit, initiate, encourage or discuss any
proposal or offer from any Person or enter into any agreement or accept any
offer relating to any Acquisition Proposal, or (ii) furnish any information
with respect to, assist or participate in or facilitate in any other manner an
effort or attempt by any Person to effect or seek to effect any Acquisition
Proposal; provided, that nothing in this Section 3 shall limit or affect any
actions taken by such Stockholder in such Stockholder’s fiduciary capacity as an
officer or director of the Company. Each Stockholder hereby represents that it
is not now engaged in discussions or negotiations with any party other than
Acquiror with respect to any Acquisition Proposal.  Each Stockholder
shall (i) promptly notify Acquiror (orally and in writing) if any offer is made
to such Stockholder, any discussions or negotiations are sought to be initiated
with such Stockholder, any inquiry, proposal or contact is made or any
information is requested from such Stockholder with respect to any Acquisition
Proposal, (ii) promptly notify Acquiror of the terms of any proposal that such
Stockholder may receive in respect of any Acquisition Proposal, and the identity
of the prospective purchaser, (iii) promptly provide Acquiror with a copy of any
such offer, if written, or a written summary of such offer, if not in writing,
and (iv) promptly keep Acquiror informed in all material respects of the status
and details (including material amendments or proposed material amendments) of
any such Acquisition Proposal of which such Stockholder is aware.

     

    ARTICLE
IV

    REPRESENTATIONS
AND WARRANTIES OF STOCKHOLDER

     

    Each
Stockholder hereby represents and warrants to Acquiror as follows:

     

    Section
4.1.          Authority. Such Stockholder
has all legal capacity and authority to execute and deliver this Agreement and
to consummate the transactions contemplated hereby.  This Agreement
has been duly executed and delivered by such Stockholder and constitutes a valid
and binding obligation of such Stockholder, enforceable in accordance with its
terms.

    
      
         

      

      
        - 3
-

        
          

        

      

      
         

      

    

     

    Section
4.2.          Ownership of Shares. As of the
date hereof, such Stockholder is the lawful owner of the Owned Shares and has
the sole power to vote (or cause to be voted) and dispose of such Owned
Shares.  Such Stockholder holds that number of certificated Owned
Shares and uncertificated Owned Shares, in each case, as identified on Schedule A hereto.
Other than the Subject Shares and options to purchase Common Stock, as
identified on Schedule
A (which Schedule identifies any such exception by Stockholder), such
Stockholder does not own or hold any right to acquire any additional shares of
any class of capital stock of the Company or other securities of the Company or
any interest therein or any voting rights with respect to any securities of the
Company. The Subject Shares are not subject to any voting trust agreement or
other written or oral contracts, agreement, arrangement, commitment or
understanding to which such Stockholder is party restricting or otherwise
relating to the voting, dividend rights or disposition of the Subject Shares,
other than those created by this Agreement.  Such Stockholder has good
and valid title to the Owned Shares, free and clear of any and all pledges,
mortgages, liens, charges, proxies, voting agreements, encumbrances, adverse
claims, options, security interests and demands of any nature or kind
whatsoever, other than those created by this Agreement.

     

    Section
4.3.          No Conflicts. (a) No filing
with any Governmental Authority, and no authorization, consent or approval of
any other Person is necessary for the execution of this Agreement by such
Stockholder and the consummation by such Stockholder of the transactions
contemplated hereby and (b) none of the execution and delivery of this Agreement
by such Stockholder, the consummation by such Stockholder of the transactions
contemplated hereby or compliance by such Stockholder with any of the provisions
hereof shall (i) result in, or give rise to, a violation or breach of or a
default under any of the terms of any material contract, understanding,
agreement or other instrument or obligation to which such Stockholder is a party
or by which such Stockholder or any of its Subject Shares or assets may be
bound, or (ii) violate any Applicable Law which could reasonably be
expected to adversely affect such Stockholder’s ability to perform its
obligations under this Agreement.

     

    Section
4.4.          Reliance by Acquiror. Such
Stockholder understands and acknowledges that Acquiror is entering into the
Purchase Agreement in reliance upon the execution and delivery of this Agreement
by such Stockholder.

     

    ARTICLE
V

    TERMINATION

     

    Section
5.1.          Termination. This Agreement
shall terminate, and neither Acquiror nor any Stockholder shall have any rights
or obligations hereunder and this Agreement shall become null and void and have
no effect upon the earliest to occur of (i) the mutual consent of Acquiror and
the Stockholders to terminate this Agreement, (ii) the termination of the
Purchase Agreement in accordance with the terms thereof, (iii) the Closing Date,
and (iv) the first anniversary of the date hereof; provided, however, that the
termination of this Agreement shall not prevent any party hereunder from seeking
any remedies (at law or in equity) against any other party hereto for such
party’s breach of any of the terms of this Agreement. Notwithstanding the
foregoing, Section 6.1 and Sections 6.4 through 6.18, inclusive, of this
Agreement shall survive the termination of this Agreement.

     

    ARTICLE
VI

    MISCELLANEOUS

     

    Section
6.1.          Appraisal Rights. To the
extent permitted by applicable law, each Stockholder hereby waives any rights of
appraisal or rights to dissent from the Acquisition that such Stockholder may
have under applicable law.

    
      
         

      

      
        - 4
-

        
          

        

      

      
         

      

    

     

    Section
6.2.          Publication.

     

    (a)           Each
Stockholder agrees that, during the Voting Period, such Stockholder shall not
issue any public release or announcement concerning the transactions
contemplated by this Agreement and the Purchase Agreement without the prior
consent of Acquiror, except as such release or announcement may, upon the advice
of such Stockholder’s counsel, be required by Applicable Law, in which case such
Stockholder shall inform the Acquiror prior to the issuance thereof and shall
reasonably consult with the Acquiror regarding thereof.

     

    (b)           Each
Stockholder hereby permits Acquiror and/or the Company to publish and disclose
in press releases and any other disclosures or filings required by Applicable
Law, its identity and ownership of shares of the Common Stock, the nature of its
commitments, arrangements and understandings pursuant to this Agreement and/or
the entire text of this Agreement.

     

    Section
6.3.          Further Actions. Each of the
parties hereto agrees that it will use its reasonable best efforts to do all
things reasonably necessary to effectuate this Agreement.

     

    Section
6.4.          Fees and Expenses. Except as
otherwise provided herein, each of the parties shall be responsible for its own
fees and expenses (including, without limitation, the fees and expenses of
financial consultants, investment bankers, accountants and counsel) in
connection with the entering into of this Agreement and the consummation of the
transactions contemplated hereby and the Purchase Agreement, regardless of
whether the Acquisition is consummated.

     

    Section
6.5.          Amendments, Waivers, etc. This
Agreement may not be amended, changed, supplemented, waived or otherwise
modified, except upon the execution and delivery of a written agreement executed
by each of the parties hereto. The failure of any party hereto to exercise any
right, power or remedy provided under this Agreement or otherwise available in
respect hereof at law or in equity, or to insist upon compliance by any other
party hereto with its obligations hereunder, and any custom or practice of the
parties at variance with the terms hereof shall not constitute a waiver by such
party of its right to exercise any such or other right, power or remedy or to
demand such compliance.

     

    Section
6.6.          Remedies.

     

    (a)           Each
Stockholder acknowledges that irreparable damage would occur and that it will be
impossible to measure in money the damage to Acquiror if such Stockholder fails
to comply with the obligations imposed by this Agreement, and that, in the event
of any such failure, Acquiror will not have an adequate remedy at law or in
damages. Accordingly, each Stockholder agrees that injunctive relief or any
other equitable remedy, in addition to any remedies at law or damages, is the
appropriate remedy for any such failure and will not oppose the granting of any
such remedy on the basis that Acquiror has an adequate remedy at law. Each
Stockholder agrees not to seek, and agrees to waive any requirement for, the
securing or posting of a bond in connection with Acquiror seeking or obtaining
such equitable relief.

     

    (b)           Each
Stockholder also agrees that in the event that such Stockholder fails to comply
with any of its obligations imposed by this Agreement, Acquiror shall be
entitled to recover all costs and expenses incurred by Acquiror or its
Affiliates, including reasonable attorneys’ fees and costs, in addition to any
other remedies to which Acquiror or its Affiliates may be entitled at law or in
equity.

     

    Section
6.7.          Notices. Any notices or other
communications required or permitted under, or otherwise in connection with this
Agreement shall be in writing and shall be deemed to have been duly given when
delivered in person or upon confirmation of receipt when transmitted by
facsimile transmission (with confirmation) or on receipt after dispatch by
registered or certified mail, postage prepaid, addressed, or on the next
business day if transmitted by national overnight courier, in each case as
follows:

    
      
         

      

      
        - 5
-

        
          

        

      

      
         

      

    

     

    If to
Acquiror, addressed to it at:

     

    Fresenius
USA, Inc.

    920
Winter Street

    Waltham,
MA 02451-1457

    Attn:
Douglas Kott

    Facsimile
No. (781) 699-9698

    Email:
doug.kott@fmc-na.com

    

    If to a
Stockholder: addressed to such Stockholder as set forth on Schedule
A

     

    Section
6.8.          Headings. The headings
contained in this Agreement are for reference purposes only and shall not affect
in any way the meaning or interpretation of this Agreement.

     

    Section
6.9.          Severability. If any term or
other provision of this Agreement is invalid, illegal or incapable of being
enforced by any rule of Applicable Law or public policy, all other conditions
and provisions of this Agreement shall nevertheless remain in full force and
effect. Upon such determination that any term or other provision is invalid,
illegal or incapable of being enforced, the parties hereto shall negotiate in
good faith to modify this Agreement so as to effect the original intent of the
parties as closely as possible in an acceptable manner to the end that
transactions contemplated hereby are fulfilled to the extent
possible.

     

    Section
6.10.        Entire Agreement. This
Agreement (together with the Purchase Agreement, the schedules and exhibits
thereto and other documents and agreements delivered pursuant to the Purchase
Agreement, to the extent referred to herein) constitutes the entire agreement of
the parties and supersedes all prior agreements and undertakings, both written
and oral, between the parties, or any of them, with respect to the subject
matter hereof.

     

    Section
6.11.        Assignment. This Agreement
shall not be assigned by operation of law or otherwise without the prior written
consent of each of the parties, except that Acquiror may assign and transfer its
rights and obligations hereunder to any entity that is wholly owned, directly or
indirectly, by Acquiror.

     

    Section
6.12.        Certain Events. Stockholder
agrees that this Agreement and the obligations hereunder shall attach to the
Subject Shares and shall be binding upon any Person or entity to which legal or
beneficial ownership of such Subject Shares shall pass, whether by operation of
law, or otherwise.

     

    Section
6.13.        Parties in Interest. This
Agreement shall be binding upon and inure solely to the benefit of each party
hereto and their respective successors and assigns, and nothing in this
Agreement, express or implied, is intended to or shall confer upon any other
Person any right, benefit or remedy of any nature whatsoever under or by reason
of this Agreement.

     

    Section
6.14.        Mutual
Drafting.  Each party hereto has participated in the drafting
of this Agreement, which each party acknowledges is the result of extensive
negotiations between the parties.

     

    Section
6.15.        Review By
Counsel.  Each Stockholder acknowledges that the Stockholder
(a) has read this Agreement; (b) understands that this Agreement
constitutes certain binding obligations upon the part of the Stockholder;
(c) has been fully advised by legal counsel; and (d) intends to be
bound personally and legally by this Agreement.

    
      
         

      

      
        - 6
-

        
          

        

      

      
         

      

    

     

    Section
6.16.        Governing
Law.  This Agreement and the transactions contemplated hereby,
and all disputes between the parties under or related to the Agreement or the
facts and circumstances leading to its execution, whether in contract, tort or
otherwise, shall be governed by and construed in accordance with the laws of the
State of Delaware, without regard to the application of Delaware principles of
conflicts of law.

     

    Section
6.17.        Counterparts. This Agreement
may be executed in two or more counterparts, and by the different parties hereto
in separate counterparts, each of which when executed shall be deemed to be an
original but all of which taken together shall constitute one and the same
agreement.

     

    Remainder
of Page Intentionally Left Blank

     

    Signature
Page Follows

    
      
         

      

      
        - 7
-

        
          

        

      

      
         

      

    

    IN
WITNESS WHEREOF, Acquiror and the Stockholders have caused this Agreement to be
duly executed as of the day and year first above written.

     

    
      
        	
                FRESENIUS
      USA, INC.

              
	 
      
	
                By:

              	
                /s/ Mohsen
      Reihany

              
	
                Name:  

              	Mohsen
      Reihany
	
                Title:

              	Senior
      Advisor To Chairman of The
Board

      

    

    
      
         

      

      
        - 8
-

        
          

        

      

      
         

      

    

    

    
      
        
          
            
              
                	
                        STOCKHOLDERS:

                      
	 
      
	
                        /s/ Terren S.
      Peizer

                      
	
                        Terren
      S. Peizer

                      
	 
	 
	
                        Jay
      A. Wolf

                      
	 
      
	
                        /s/ Kelly J. McCrann
      

                      
	
                        Kelly
      J. McCrann

                      
	 
      
	
                        /s/ Robert
      Weinstein

                      
	
                        Robert
      Weinstein

                      

              

            

          

        

      

    

    

    [Signature
Page to Voting Agreement]

    
      
         

      

      
        
        

        
          

        

      

      
         

      

    

    

    Schedule
A

    

    
      
        
          
            	
                    Name of Stockholder (including address)

                  	 	
                    Common Stock

                  	 	 	
                    Options

                  	 
	
                    Terren
      S. Peizer

                  	 	 	6,232,596	 	 	 	700,000	 
	
                    Kelly
      J. McCrann

                  	 	 	100,000	 	 	 	800,000	 
	
                    Robert
      Weinstein

                  	 	 	20,000	 	 	 	300,000

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}]]